- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00015275
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
January 11, 2017 updated by: National Institute on Drug Abuse (NIDA)
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence
The purpose of this study is to define pathophysiological subtypes of abnormalities in subjects with cocaine dependence.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The objective of this study is to define subgroups of patients with differential treatment outcome on the basis of differential baseline electrophysiological clusters.
Study Type
Interventional
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10010
- New York MDRU
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
Cocaine dependence. Seeking residential treatment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Identification of homogenous subgroups within total population of cocaine dependent adults
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: John Rotrosen, M.D., New York MDRU
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
April 18, 2001
First Submitted That Met QC Criteria
April 17, 2001
First Posted (Estimate)
April 18, 2001
Study Record Updates
Last Update Posted (Estimate)
January 12, 2017
Last Update Submitted That Met QC Criteria
January 11, 2017
Last Verified
December 1, 2002
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Chemically-Induced Disorders
- Pathologic Processes
- Substance-Related Disorders
- Disease
- Cocaine-Related Disorders
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Neurotransmitter Uptake Inhibitors
- Membrane Transport Modulators
- Dopamine Agents
- Anesthetics, Local
- Dopamine Uptake Inhibitors
- Vasoconstrictor Agents
- Cocaine
Other Study ID Numbers
- NIDA-5-0013-9
- Y01-5-0013-9
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance-Related Disorders
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Substance Use | Substance Use Disorders | Substance Abuse | Substance Dependence | Substance Related Problem
-
US Department of Veterans AffairsCompletedAlcoholism | Substance Use Disorders | Substance Abuse | Alcohol Abuse | Substance DependenceUnited States
-
VA Office of Research and DevelopmentRecruiting
-
National Institute on Drug Abuse (NIDA)CompletedSubstance-related Disorders
-
Norwegian University of Science and TechnologyCompletedSubstance-related DisordersNorway
-
University of Southern CaliforniaNational Institute on Drug Abuse (NIDA)Completed
-
University Hospital, Basel, SwitzerlandPsychiatric Hospital of the University of BaselCompleted
-
University of LuebeckFederal Ministry of Health, GermanyCompletedSubstance-related Disorders
-
University of Illinois at Urbana-ChampaignCompletedSubstance-related Disorders
-
University of NebraskaCompletedSubstance-related Disorders | Alcohol-related DisordersUnited States
Clinical Trials on Cocaine-Related Disorders
-
T.C. ORDU ÜNİVERSİTESİHacettepe University; Giresun UniversityCompletedPain | Occupational Problems | Work-related Injury | Musculoskeletal StrainTurkey
-
National Institute on Drug Abuse (NIDA)CompletedCocaine-Related DisordersUnited States
-
University of AarhusCompletedHeart Failure | Stroke | Epilepsy | Pain | Multiple Sclerosis | Hypertension | Diabetes Mellitus | Cancer | Chronic Kidney Diseases | Schizophrenia | Parkinson Disease | Migraine | Inflammatory Bowel Diseases | Anemia | HIV/AIDS | Atrial Fibrillation | Dyslipidemias | Allergy | Osteoporosis | Ischemic Heart Disease | Hearing Disorders | Substance... and other conditions
-
University Hospital of North NorwayUniversity of TromsoCompleted
-
Tampere University HospitalTampere University; Coxa, Hospital for Joint ReplacementCompletedDelirium | Cognitive Impairment | Malnutrition | Dementia
-
University of LouisvilleNational Institute of Mental Health (NIMH)Recruiting
-
University of Colorado, DenverNational Institute on Drug Abuse (NIDA)WithdrawnOpioid-Related Disorders | Heroin DependenceUnited States
-
Vascular Insights, LLCTerminatedVenous InsufficiencyUnited States
-
Modum BadCompletedPosttraumatic Stress Disorder | Dissociative Identity Disorder | Dissociative DisorderNorway
-
Universitat Jaume IMinisterio de Economía y Competitividad, SpainUnknownOnline Computerized Program Group | Waiting List Control GroupSpain